BIOVICA
Biovica develops and commercializes blood-based biomarker assays that improve monitoring of modern cancer therapies and predict patient outcome. The company’s DiviTum™ assay, a test for accurately measuring cell proliferation, has successfully demonstrated its capabilities to early evaluate therapy effectiveness in several clinical trials. Biovica aims to make best-possible-treatment from day one a reality. Biovica collaborates with world-leading cancer institutes as well as pharmaceutical companies launching next-generation therapies. The company is ISO 13485 certified for Quality Management Systems. DiviTum™ is CE-labeled and MPA-registered.
BIOVICA
Industry:
Biotechnology Health Care Health Diagnostics Medical Medical Device
Founded:
2009-01-01
Address:
Uppsala, Uppsala Lan, Sweden
Country:
Sweden
Website Url:
http://www.biovica.com
Total Employee:
11+
Status:
Active
Contact:
+46 (0) 18 44 44 830
Email Addresses:
[email protected]
Technology used in webpage:
SPF LetsEncrypt Microsoft Exchange Online Amazon Office 365 Mail CPanel SSL CPanel DocuSign FreshService
Similar Organizations
Bone Vitae
Bone Vitae is a start-up enterprise that commercializes a low-cost device detecting early indications of osteoporosis.
Canostix
Canostix is developing a multi-cancer screening blood test that combines photonics and machine learning.
Healeon Medical, Inc.
Develop and commercialize next generation protocols that improve isolation of regenerative cells.
HealthCare Partners
Since 1992, HealthCare Partners has been committed to developing innovative models of healthcare delivery that improve our patients'
SOMAprobes
SOMAprobes develops and commercializes diagnostic innovations based on the biology of nucleases.
Current Employees Featured
Official Site Inspections
http://www.biovica.com
- Host name: oshi.wasabiweb.se
- IP address: 85.24.159.71
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
